Erasmus MC kiest voor off-label-toepassing bevacizumab

Bregje Witjes, Hans Vingerling, PD Knoester, Andras Vermes

Research output: Contribution to journalArticleProfessional

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1328-1329
Number of pages2
JournalPharmaceutisch Weekblad
Volume42
Publication statusPublished - 2006

Cite this